🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this phase 0 proof-of concept study is to measure the therapeut...
Status
Unknown
Location
Division of Nuclear Medicine, University Hospital Basel
Start Date
2023-03-28
Trial ID
NCT05359146
Treatments Being Tested
The purpose of the study was to evaluate the effect of arginine/lysine solu...
Status
Completed
Location
Istituto Europeo di Oncologia
Start Date
2021-01-25
Trial ID
NCT04524442
Treatments Being Tested
Neuroendocrine tumours (NETs) are slow growing cancers, which commonly pres...
Status
Recruiting
Location
Royal North Shore Hospital
Start Date
2024-10-14
Trial ID
NCT06345079
Treatments Being Tested
First in Human (FIH) study to characterize the safety, tolerability, pharma...
Status
Completed
Location
City of Hope
Start Date
2019-07-24
Trial ID
NCT03872778
Treatments Being Tested
The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Status
Withdrawn
Location
Jules Bordet Institute
Start Date
2014-12
Trial ID
NCT01860742
Treatments Being Tested
The purpose of this study is to determine the use of 177Lu-PP-F11N for imag...
Status
Completed
Location
University Hospital Basel, Clinic for radiology and nuclear medicine
Start Date
2018-12-13
Trial ID
NCT03647657
Treatments Being Tested
This pilot phase II trial studies how effective pembrolizumab and liver-dir...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-08-27
Trial ID
NCT03457948
This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2017-09-29
Trial ID
NCT03273712
This is a randomized phase II non-comparative study. Patients with gastroen...
Status
Terminated
Location
Irst Irccs
Start Date
2013-12
Trial ID
NCT02489604
Treatments Being Tested
Background: A neuroendocrine tumor is a rare type of tumor. It comes from ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-10-03
Trial ID
NCT04086485
Treatments Being Tested